Evoke Pharma, Inc. (EVOK)
Largest Insider Buys in Sector
EVOK Stock Price History Chart
EVOK Stock Performance
About Evoke Pharma, Inc.
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was …
Insider Activity of Evoke Pharma, Inc.
Over the last 12 months, insiders at Evoke Pharma, Inc. have bought $0 and sold $0 worth of Evoke Pharma, Inc. stock.
On average, over the past 5 years, insiders at Evoke Pharma, Inc. have bought $0 and sold $343,844 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 500,000 shares for transaction amount of $1.18M was made by LVP GP III, LLC (10 percent owner) on 2018‑08‑20.
List of Insider Buy and Sell Transactions, Evoke Pharma, Inc.
| 2020-12-14 | Sale | President and CEO | 23,954 0.0936% | $2.94 | $70,425 | -54.58% | ||
| 2020-12-11 | Sale | President and CEO | 48,046 0.1885% | $2.90 | $139,333 | -53.45% | ||
| 2020-12-11 | Sale | Exec VP, Chief Bus. Officer | 40,357 0.1589% | $2.91 | $117,439 | -53.45% | ||
| 2020-12-10 | Sale | Exec VP, Chief Bus. Officer | 5,643 0.0226% | $2.95 | $16,647 | -53.29% | ||
| 2018-08-20 | 10 percent owner | 500,000 2.8821% | $2.35 | $1.18M | -2.52% | |||
| 2017-02-22 | director | 450,000 3.0145% | $2.90 | $1.3M | -17.03% | |||
| 2016-05-26 | Sale | 10 percent owner | 688,240 8.3615% | $4.70 | $3.23M | -52.42% | ||
| 2016-05-26 | Sale | 10 percent owner | 11,760 0.1429% | $4.70 | $55,272 | -52.42% | ||
| 2016-04-27 | Sale | 10 percent owner | 7,206 0.1042% | $5.02 | $36,174 | -46.99% | ||
| 2016-04-27 | Sale | 10 percent owner | 122 0.0018% | $5.02 | $612 | -46.99% | ||
| 2016-04-25 | Sale | 10 percent owner | 2,984 0.0409% | $5.20 | $15,517 | -51.43% | ||
| 2016-04-25 | Sale | 10 percent owner | 42 0.0006% | $5.20 | $218 | -51.43% | ||
| 2016-04-20 | Sale | 10 percent owner | 8,848 0.1254% | $5.29 | $46,806 | -50.19% | ||
| 2016-04-20 | Sale | 10 percent owner | 152 0.0022% | $5.29 | $804 | -50.19% | ||
| 2016-04-19 | Sale | 10 percent owner | 74,108 1.0666% | $5.36 | $397,219 | -50.00% | ||
| 2016-04-19 | Sale | 10 percent owner | 1,264 0.0182% | $5.36 | $6,775 | -50.00% | ||
| 2016-04-11 | Sale | 10 percent owner | 8,696 0.1207% | $5.22 | $45,393 | -50.10% | ||
| 2016-04-11 | Sale | 10 percent owner | 150 0.0021% | $5.22 | $783 | -50.10% | ||
| 2016-04-08 | Sale | 10 percent owner | 29,108 0.4165% | $5.35 | $155,728 | -50.19% | ||
| 2016-04-08 | Sale | 10 percent owner | 502 0.0072% | $5.35 | $2,686 | -50.19% |